Prostate cancer, Secondary cancers
Results
Phase 2
This trial looked at docetaxel with or without saracatinib for prostate cancer that had spread outside the prostate despite other treatment.
The trial was supported by Cancer Research UK. People could join between 2013 and 2016. The team presented the results at a conference in 2021.
Recruitment start: 16 October 2013
Recruitment end: 30 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert J Jones
AstraZeneca
Beatson Oncology Centre
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NHS Greater Glasgow and Clyde
NIHR Clinical Research Network: Cancer
University of Glasgow
This is Cancer Research UK trial number CRUKE/10/043.
Last reviewed: 19 Feb 2026
CRUK internal database number: 6192
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
